RSS
14 Sep 2021

NanoViricides Completes Licensing for Coronavirus Field which Includes Current COVID-19 Drug Development

Author: admintech | Filed under: Press Release

SHELTON, Conn., Sept. 14, 2021 /PRNewswire/ — NanoViricides, Inc. (NYSE Amer.: NNVC) (the “Company”), a global leader in nanomedicines against viruses, announced today that it has completed the process of licensing the human Coronavirus field for drug development and commercialization…

This entry was posted on Tuesday, September 14th, 2021 at 5:57 am and is filed under Press Release. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

«

»